✦ LIBER ✦

Is neonatal screening a disease modifier?

✍ Scribed by Gartner, S.

Book ID: 121781820
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 14
Category: Article
ISSN: 1526-0550
DOI: 10.1016/S1526-0542(13)70029-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neonatal biochemical screening for disea

Neonatal biochemical screening for disease

✍ Alan Clague; Andrew Thomas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Neonatal sepsis screening re hemolytic d

Neonatal sepsis screening re hemolytic disease

✍ Marilyn H. Duncan; Kristi L. Watterberg 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A mutation in SCARB2 is a modifier in ga

A mutation in SCARB2 is a modifier in gaucher disease

✍ Arash Velayati; John DePaolo; Nidhi Gupta; Jae H. Choi; Nima Moaven; Wendy Westb 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Lysosomal integral membrane protein type 2 (LIMP-2) is responsible for proper sorting and lysosomal targeting of glucocerebrosidase, the enzyme deficient in Gaucher disease (GD). Mutations in the gene for LIMP-2, SCARB2, are implicated in inherited forms of myoclonic epilepsy, and myoclonic epilepsy

The splicing machinery is a genetic modi

The splicing machinery is a genetic modifier of disease severity

✍ Malka Nissim-Rafinia; Batsheva Kerem 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Neonatal Genetic Testing is More Than Sc

Neonatal Genetic Testing is More Than Screening

✍ Kenner, Carole; Lewis, Judith A.; Pressler, Jana L.; Little, Cindy M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 134 KB

There is a lack of evidence from trials

There is a lack of evidence from trials of neonatal screening for sickle cell disease

✍ STREETLY, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 244 KB